glp retatrutide Retatrutide (LY3437943) | GCGR/GLP-1R Inhibitor
Description
The findings, published in JAMA, also showed that prescription rates of these medications were low overall.
Discover the benefits of GLP-1 weight loss medication in Las Vegas for weight management
To: NACDS Chain Members From: Steven C
Objective To systematically evaluate the efficacy and safety of GLP-1 RAs in IIH, based on clinical studies reporting outcomes related to ICP, headache, vision, cognition, weight loss, and safety
The study found 4% of users reported "menstrual irregularities," according to Neil Sehgal, the study's first author.
